P4ADNow CEO Testifies Before Senate Judiciary Committee, Urges Congress To Advance Bipartisan Drug Price Reforms Before Year-End
P4AD CEO Merith Basey’s Opening Testimony: Merith highlighted how patent abuses delay competition and keep prices high for American patients. She shared the experiences of patient advocate Kevin Baker and P4ADNow founder David Mitchell to underscore why patients need both innovation and affordability. Watch the full video here.